StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Convertible Debentures $200,000 CAD

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Aug 23, 2022 7:27pm

119 Views

Post# 34915710

RE:Convertible Debentures $200,000 CAD

Now I understand why they didn't told any numbers about Aristotle's sale it's because they make too much money

Same reason why they did a low financing of $177k they make to much money

Right on - The Big Lebowski Dude | Meme Generator

Ancient Aliens Meme - Imgflip

LithLover wrote: The news release was in USD. Hence the $177,000 amount. The total is $200,000 CAD for those wondering why it was such a strange amount.

“Offering” means private placement pursuant to which the Corporation will issue up to 200 units, each of which is comprised of (i) $1,000 in principal amount of 8% unsecured convertible debentures, and (ii) 9,090 common share purchase warrants, up to an aggregate value of CAD$200,000;

Cash on hand June 30, 2022 $90,626.

Expenses for Q2: $1,191,935 or $639,978 per month or $21,000 per day.